• WECF News & Reports
• News from other sources

Phthalate producers consider options under REACH

DEHP is on the EU candidate list but there is an exemption for medical uses

16.08.2010 |CW Briefing

---

As DEHP is on the EU candidate list, there is an exemption for medical uses, so this means when we have it phased out in other applications in Europe the marketing and sale in medical products will continue. Our goal is to extend the scope of the REACH law to cover DEHP in medical products at the review in 2012. But it also means that the only shift can currently come from the market, from procurement of our members.

According to REACH Article 60.2 on the granting of authorisations, the
European Commission will not consider risks to human health arising from
the use of a substance in medical devices regulated by any of three
existing EU Directives on medical devices, and this provision - as
Arkema general manager David Royer points out - will apply to the use of
DEHP in blood bags. “We are, of course, very committed and confident
to go on selling in this application.” Arkema is not working yet on
the development of alternatives for low molecular weight phthalates such
as DEHP.


To read an article “Phthalate producers consider options under REACH” visit http://chemicalwatch.com/3989?q=phthalates

---

Related News

Annual Report WECF 2016

WECF Strategic Plan 2015-2020